CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Lexaria Bioscience Corp.  (LXRP)
Other Ticker:  
 
 

LXRP's Revenue Growth by Quarter and Year

Lexaria Bioscience.'s Revenue results by quarter and year




LXRP Revenue (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter August 0.11 0.94 0.38 0.72
III Quarter May 0.14 0.03 0.13 -
II Quarter February 0.17 0.01 0.13 -
I Quarter November 0.02 0.28 0.01 0.14
FY   0.44 1.26 0.65 0.86



LXRP Revenue forth quarter 2018 Y/Y Growth Comment
Lexaria Bioscience Corp. reported drop in Revenue in the forth quarter by -88.37% to $ 0.11 millions, from the same quarter in 2017.
The fall in the forth quarter Lexaria Bioscience Corp.'s Revenue compares unfavorably to the Company's average Revenue decrease of -2.5%.

Looking into forth quarter results within Legal Marijuana industry 3 other companies have achieved higher Revenue growth. While Lexaria Bioscience Corp.' s Revenue meltdown of -88.37% ranks overall at the positon no. 3216 in the forth quarter.




LXRP Revenue ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter August -88.37 % 147.37 % -47.22 % 323.53 %
III Quarter May 366.67 % -76.92 % - -
II Quarter February 1600 % -92.31 % - -
I Quarter November -92.86 % 2700 % -92.86 % -44 %
FY   -65.13 % 93.85 % -24.42 % -

Financial Statements
Lexaria Bioscience.'s forth quarter 2018 Revenue $ 0.00 millions LXRP's Income Statement
Lexaria Bioscience.'s forth quarter 2017 Revenue $ 0.00 millions Quarterly LXRP's Income Statement
New: More LXRP's historic Revenue Growth >>


LXRP Revenue (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter August -21.91 % 3033.33 % 192.31 % -
III Quarter May -17.65 % 200 % 0 % -
II Quarter February 750 % -96.43 % 1200 % -
I Quarter November -97.87 % -26.32 % -98.61 % -17.65 %
FY (Year on Year)   -65.13 % 93.85 % -24.42 % -




Revenue forth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Legal Marijuana Industry #4
Consumer Non Cyclical Sector #110
Overall #3216

Revenue Y/Y Growth Statistics
High Average Low
79.56 % -2.5 % -65.06 %
(Aug 31 2017)   (Aug 31 2018)
Revenue forth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Legal Marijuana Industry #4
Consumer Non Cyclical Sector #110
Overall #3216
Revenue Y/Y Growth Statistics
High Average Low
79.56 % -2.5 % -65.06 %
(Aug 31 2017)   (Aug 31 2018)

Revenue by Quarter for the Fiscal Years 2015, 2016, 2017, 2018

Lexaria Bioscience.'s Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
3114.59 % 221.29 % -98.5 %
(Aug 31 2017)  


LXRP's IV. Quarter Q/Q Revenue Comment
In the IV. Quarter 2018 Lexaria Bioscience Corp. realized fall in Revenue sequentially by -21.91% to $ 0.11 millions, from $ 0.14 millions released a quarter before.

Those periodic circumstance that commonly energize IV. Quarter 2018 results, have not rescue the IV. Quarter for the Lexaria Bioscience Corp., Alexandra Lyons, Consumer Non Cyclical sector veteran said.

Within Legal Marijuana industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Lexaria Bioscience.'s Revenue growth quarter on quarter, overall rank is 2938.


Revenue Q/Q Growth Company Ranking
Within: No.
Legal Marijuana Industry #5
Consumer Non Cyclical Sector #99
Overall #2938
Revenue Q/Q Growth Company Ranking
Within: No.
Legal Marijuana Industry #5
Consumer Non Cyclical Sector #99
Overall #2938
Revenue Q/Q Growth Statistics
High Average Low
3114.59 % 221.29 % -98.5 %
(Aug 31 2017)  


LXRP's IV. Quarter Q/Q Revenue Comment
In the IV. Quarter 2018 Lexaria Bioscience Corp. reported fall in Revenue sequentially by -21.91% to $ 0.11 millions, from $ 0.14 millions achived in the previous reporting period.

Even periodic circumstance which normally energize IV. Quarter 2018 Revenue, it simply has not been substantial to salvage Lexaria Bioscience.'s IV. Quarter achievement, Alexandra Lyons, Consumer Non Cyclical sector veteran wrote.

Within Legal Marijuana industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Lexaria Bioscience.'s Revenue growth quarter on quarter, overall rank is 2938.


Lexaria Bioscience.'s 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Aug 31 2018)
12 Months Ending
(May 31 2018)
12 Months Ending
(Feb 28 2018)
12 Months Ending
(Nov 30 2017)
12 Months Ending
(Aug 31 2017)
Cumulative Revenue 12 Months Ending $ 0.45 $ 1.28 $ 1.17 $ 1.01 $ 1.26
Y / Y Revenue Growth (TTM) -64.67 % 81.57 % 44.21 % 8.7 % 92.53 %
Year on Year Revenue Growth Overall Ranking # 2956 # 241 # 39 # 1344 # 3004
Seqeuential Revenue Change (TTM) -65.06 % 9.53 % 15.83 % -20.29 % 79.56 %
Seq. Revenue Growth (TTM) Overall Ranking # 3216 # 541 # 312 # 2943 # 3276




Cumulative Revenue growth Comment
For the 12 months ended Aug 31 2018 Lexaria Bioscience. reported a sharp drop in Revenue by -64.67% year on year, to $0 millions, compare to the 81.57% growth at May 31 2018.

In the Consumer Non Cyclical sector 96 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 241 to 2956.

Revenue TTM Q/Q Growth Statistics
High Average Low
79.56 %
-2.5 %
-65.06 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Legal Marijuana Industry # 4
Consumer Non Cyclical Sector # 97
Overall # 2956

Revenue TTM Y/Y Growth Statistics
High Average Low
92.53 %
-2.27 %
-64.67 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 4
Sector # 110
S&P 500 # 3216
Cumulative Revenue growth Comment
For the 12 months ended Aug 31 2018 Lexaria Bioscience. reported a sharp drop in Revenue by -64.67% year on year, to $0 millions, compare to the 81.57% growth at May 31 2018.

In the Consumer Non Cyclical sector 96 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 241 to 2956.

Revenue TTM Q/Q Growth Statistics
High Average Low
79.56 %
-2.5 %
-65.06 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Legal Marijuana Industry # 4
Consumer Non Cyclical Sector # 97
Overall # 2956

Revenue TTM Y/Y Growth Statistics
High Average Low
92.53 %
-2.27 %
-64.67 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 4
Sector # 110
S&P 500 # 3216


You need to upgrade your Flash Player




Other Revenue Growth
Legal Marijuana Industry Revenue Growth Trends and Statistics
Consumer Non Cyclical Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
LXRP's Revenue Growth Ratio versus Legal Marijuana Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for LXRP's Competitors
Revenue Growth for Lexaria Bioscience.'s Suppliers
Revenue Growth for LXRP's Customers

You may also want to know
LXRP's Annual Growth Rates LXRP's Profitability Ratios LXRP's Asset Turnover Ratio LXRP's Dividend Growth
LXRP's Roe LXRP's Valuation Ratios LXRP's Financial Strength Ratios LXRP's Dividend Payout Ratio
LXRP's Roa LXRP's Inventory Turnover Ratio LXRP's Growth Rates LXRP's Dividend Comparisons



Companies with similar Revenue sharp drop for the quarter ending Aug 31 2018 within Consumer Non Cyclical SectorY/Y Change %Revenue for the quarter ending Aug 31 2018
Bab, Inc. -1.35 %$ -1.355 millions
Rocky Mountain Chocolate Factory, Inc. -5.64 %$ -5.644 millions
Trident Brands Incorporated -49.88 %$ -49.879 millions
Lexaria Bioscience Corp. -88.37 %$ -88.375 millions
Conagra Brands Inc. -96.51 %$ -96.514 millions


     
       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

NCLH's Profile

Stock Price

NCLH's Financials

Business Description

Fundamentals

Charts & Quotes

NCLH's News

Suppliers

NCLH's Competitors

Customers & Markets

Economic Indicators

NCLH's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071